Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ANTITHROMBIN III HUMAN Cause Off label use? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Off label use have been filed in association with ANTITHROMBIN III HUMAN. This represents 18.5% of all adverse event reports for ANTITHROMBIN III HUMAN.

17
Reports of Off label use with ANTITHROMBIN III HUMAN
18.5%
of all ANTITHROMBIN III HUMAN reports
1
Deaths
4
Hospitalizations

How Dangerous Is Off label use From ANTITHROMBIN III HUMAN?

Of the 17 reports, 1 (5.9%) resulted in death, 4 (23.5%) required hospitalization, and 2 (11.8%) were considered life-threatening.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ANTITHROMBIN III HUMAN. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does ANTITHROMBIN III HUMAN Cause?

Drug ineffective (19) Contraindicated product administered (11) Prescribed overdose (11) Foetal exposure during pregnancy (9) Hepatic function abnormal (7) Hyperglycaemia (7) Premature baby (7) Adenovirus infection (5) Cholestasis (5) Diarrhoea (5)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Related Pages

ANTITHROMBIN III HUMAN Full Profile All Off label use Reports All Drugs Causing Off label use ANTITHROMBIN III HUMAN Demographics